Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00276887
Other study ID # K08MH001662
Secondary ID K08MH001662DSIR
Status Completed
Phase Phase 2
First received January 11, 2006
Last updated February 19, 2014
Start date September 1999
Est. completion date April 2004

Study information

Verified date February 2014
Source Rutgers, The State University of New Jersey
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This study will examine the long-term effects of cognitive behavioral therapy on the physical symptoms, functioning, and health care utilization of people with multiple medically unexplained physical symptoms.


Description:

Somatization disorder is a chronic psychological condition that causes numerous physical complaints for which no underlying physical problem can be identified. The disorder often lasts for several years and results in substantial functional impairment. The physical complaints most frequently involve chronic pain and problems with the digestive, nervous, and reproductive systems. Neither pharmacological nor psychosocial treatments for this disorder have been successful in suppressing symptoms. Cognitive behavioral therapy (CBT) is a treatment that focuses on maladaptive patterns of thinking and the beliefs that underlie such thinking. This study will examine the long-term effects of CBT on the physical symptoms, functioning, and health care utilization of people with somatization disorder.

Participants in this open label study will be randomly assigned to receive either CBT supplemented with augmented standard medical care (ASMC) as indicated by a psychiatric consultation letter or ASMC alone. Participants assigned to CBT plus ASMC will receive CBT for 10 weeks. Somatic symptomatology, functional impairment, and health care costs will be assessed at study visits at baseline and Months 3, 9, and 15. The visits at Months 9 and 15 will assess specifically the long-term efficacy of the treatment.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date April 2004
Est. primary completion date April 2003
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Meets DSM-IV criteria for somatization disorder

- Available for follow-up over the ensuing 15 months

- English-speaking

Exclusion Criteria:

- Meets DSM-IV criteria for a psychotic disorder, organic brain syndrome, or psychoactive substance dependence

- Active suicidal ideation

- Unstable major medical condition

- Plans to engage in additional psychotherapy during the first 3 months after study entry

- Current use of any medication that has not been stabilized for the 2 months prior to study entry

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavior Therapy

Psychiatric Consultation Letter


Locations

Country Name City State
United States Department of Psychiatry, UMDNJ - RWJ Medical School Piscataway New Jersey

Sponsors (2)

Lead Sponsor Collaborator
University of Medicine and Dentistry of New Jersey National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med. 2002 Nov-Dec;64(6):939-50. Review. — View Citation

Allen LA, Woolfolk RL, Lehrer PM, Gara MA, Escobar JI. Cognitive behavior therapy for somatization disorder: a preliminary investigation. J Behav Ther Exp Psychiatry. 2001 Jun;32(2):53-62. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Symptoms of somatization disorder
Primary Functioning (measured with the Clinical Global Impression Scale for Somatization Disorder at Months 9 and 15)
Secondary Health care utilization (measured the year before baseline and during the year after the 3-month assessment)
Secondary Health status (measured by the Medical Outcomes Study, SF-36, at Months 9 and 15)
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05565352 - Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of GdaƄsk Inpatients
Active, not recruiting NCT04847310 - Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care N/A
Completed NCT05611606 - Welfare Benefits in Functional Somatic Disorders
Completed NCT05631860 - Psychological Risk Factors for Functional Somatic Disorders
Completed NCT02151500 - Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms N/A
Completed NCT01590992 - Treatment of Globus Sensations With Psychotherapy N/A
Completed NCT00368212 - Integrated Treatment Program for Hypochondriasis in Primary Care Settings Phase 3
Completed NCT00149799 - Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder Phase 3
Terminated NCT02843932 - Subjective Perception of Motor Control During Psychogenic Disorders N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Recruiting NCT04807933 - Neurovegetative Decoupling in Somatoform Disorders : Biofeedback Interest N/A
Completed NCT01119469 - Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis Phase 3
Recruiting NCT03188861 - Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED
Recruiting NCT04835103 - Build a Research Clinic for Somatoform Patients N/A
Completed NCT02346071 - Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes N/A
Completed NCT01518647 - Acceptance and Commitment Therapy for Patients With Multi-organ Bodily Distress Syndrome (Stress-4) N/A
Completed NCT01518634 - Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome Phase 2
Recruiting NCT01391897 - Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of Psychotherapy N/A
Completed NCT01924715 - Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study N/A
Completed NCT00130988 - DEPENAS: A Psychosocial Intervention for Patients With Medically Unexplained Symptoms Phase 3